Kalaris Therapeutics (KLRS) Accounts Payables (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Accounts Payables data on record, last reported at $1.8 million in Q3 2020.
- For Q3 2020, Accounts Payables changed N/A year-over-year to $1.8 million; the TTM value through Sep 2020 reached $1.8 million, changed N/A, while the annual FY2019 figure was $630000.0, N/A changed from the prior year.
- Accounts Payables reached $1.8 million in Q3 2020 per KLRS's latest filing, up from $680000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.8 million in Q3 2020 and bottomed at $630000.0 in Q4 2019.